Lactobacillus johnsonii is a dominant Lactobacillus in the murine oral mucosa and has chitinase activity that compromises fungal cell wall integrity
mBio · 2024
DOI: 10.1128/mbio.02416-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Roberto Vazquez-Munoz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Dentistry, the University of Connecticut Health Center, Farmington, Connecticut, USA. Hauptthemen laut MEDLINE: Cell Wall, Mice, Inbred C57BL, Mouth Mucosa, Candida albicans. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, HHS | National Institutes of Health (NIH).
Abstract (Originalsprache)
The oral microbiome is a critical determinant of health and disease, as interactions between oral microorganisms can influence their physiology and the development or severity of oral infections. Lactobacilli have a widely recognized antagonistic relationship with Candida albicans and may exhibit probiotic properties that limit oral fungal infection. We previously reported that Lactobacillus johnsonii strain MT4, an oral strain isolated from C57BL/6 mice, can induce global changes in the murine oral microbiome and has anti- Candida activity in vitro . To build on this information, we analyzed its abundance on the mouse oral mucosa, tested its impact on the severity and progression of oropharyngeal candidiasis (OPC) in a mouse model, and further explored the mechanism of antifungal activity in vitro . Our findings reveal that L. johnsonii MT4 is a dominant cultivable Lactobacillus in the oral mucosa of C57BL/6 mice. Strain MT4 has chitinase activity against C. albicans , which damages the cell wall and compromises fungal metabolic activity. Oral inoculation with strain MT4 causes a reduction in the Candida -induced rise in the abundance of oral enterococci and oral mucosal damage. This research underscores the potential of L. johnsonii strain MT4 as a novel probiotic agent in the prevention or management of OPC, and it contributes to a better understanding of the role of oral bacterial microbiota role in the pathogenesis of fungal infections. IMPORTANCE The interactions between the opportunistic pathogen Candida albicans and resident oral bacteria are particularly crucial in maintaining oral health. Emerging antifungal drug-resistant strains, slow-paced drug discovery, and the risk of side effects can compromise the effectiveness of current treatments available for oropharyngeal candidiasis. This study advances the search for alternative microbiome-targeted therapies in oral fungal infections. We report that Lactobacillus johnsonii strain MT4 prevents the Candida -induced bloom of dysbiotic oral enterococci and reduces oral mucosal lesions in an oropharyngeal candidiasis murine model. We also show that this strain directly compromises the cell wall and reduces fungal metabolic activity, partly due to its chitinase activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Dentistry, the University of Connecticut Health Center, Farmington, Connecticut, USA.
ORCID-Profile: Anna Dongari-Bagtzoglou
Förderung
- NIDCR NIH HHS
- HHS | National Institutes of Health (NIH)
Zitieren
APA
Vazquez-Munoz, R., Thompson, A., Sobue, T., & Dongari-Bagtzoglou, A. (2024). Lactobacillus johnsonii is a dominant Lactobacillus in the murine oral mucosa and has chitinase activity that compromises fungal cell wall integrity. mBio. https://doi.org/10.1128/mbio.02416-24
Vancouver
Vazquez-Munoz R, Thompson A, Sobue T, Dongari-Bagtzoglou A. Lactobacillus johnsonii is a dominant Lactobacillus in the murine oral mucosa and has chitinase activity that compromises fungal cell wall integrity. mBio. 2024. doi:10.1128/mbio.02416-24
BibTeX
@article{VazquezMunoz2024,
author = {Vazquez-Munoz, Roberto and Thompson, Angela and Sobue, Takanori and Dongari-Bagtzoglou, Anna},
title = {Lactobacillus johnsonii is a dominant Lactobacillus in the murine oral mucosa and has chitinase activity that compromises fungal cell wall integrity},
journal = {mBio},
year = {2024},
doi = {10.1128/mbio.02416-24}
}
EUVIMED